Low‐grade prostate cancer should still be labelled cancer.

MLA

Iczkowski, Kenneth A., et al. “Low‐grade Prostate Cancer Should Still Be Labelled Cancer.” BJU International, vol. 130, no. 6, Dec. 2022, pp. 741–43. EBSCOhost, https://doi.org/10.1111/bju.15886.

APA

Iczkowski, K. A., Molina, M., Egevad, L., Bostwick, D. G., van Leenders, G. J. L. H., La Rosa, F. G., van der Kwast, T., Berney, D. M., Evans, A. J., Wheeler, T. M., Leite, K. R. M., Samaratunga, H., Srigley, J., Varma, M., Tsuzuki, T., Lucia, M. S., Crawford, E. D., Harris, R. G., Stricker, P., & Lawrentschuk, N. (2022). Low‐grade prostate cancer should still be labelled cancer. BJU International, 130(6), 741–743. https://doi.org/10.1111/bju.15886

Chicago

Iczkowski, Kenneth A., Mariel Molina, Lars Egevad, David G. Bostwick, Geert J.L.H. van Leenders, Francisco G. La Rosa, Theodorus van der Kwast, et al. 2022. “Low‐grade Prostate Cancer Should Still Be Labelled Cancer.” BJU International 130 (6): 741–43. doi:10.1111/bju.15886.